Sign in Subscribe
Blood tests

Breakthrough Blood Test for Chronic Fatigue Syndrome (ME/CFS) Offers New Hope for Diagnosis and Treatment

Strategic Insights

— 1 min read

Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis (ME/CFS), is a debilitating long-term illness affecting millions worldwide, including over 400,000 sufferers in the UK. The condition is poorly understood and has long lacked reliable diagnostic tools. However, a new high-accuracy blood test developed by scientists at the University of East Anglia and Oxford Biodynamics offers new hope for diagnosis and treatment. The test has a 96% accuracy rate and could pave the way for a similar blood test to diagnose long Covid.

Key Takeaways:

  • The new blood test for ME/CFS has a 96% accuracy rate, making it a significant step forward in diagnosing the condition.
  • The test uses advanced EpiSwitch 3D Genomics technology to analyze DNA folds in blood samples from patients with severe ME/CFS and healthy controls.
  • The study revealed a unique pattern in people with ME/CFS that is not seen in healthy people, which was identified through the analysis of 3D genomic folds.
  • The analysis showed 92% sensitivity and 98% specificity in identifying ME/CFS, indicating the test's ability to accurately diagnose the condition.
  • The researchers also found signs of immune system and inflammation pathways involved in the disease, which may help guide future treatments and identify patients more likely to respond to specific therapies.
  • The study highlights the potential for the EpiSwitch platform to deliver practical, rapid blood diagnostics for complex conditions like ME/CFS.
  • Prof Dmitry Pshezhetskiy, lead researcher, stated that the discovery offers new hope for those living with ME/CFS, which is often misunderstood and misdiagnosed.
  • The researchers aim to use the test as a vital tool for diagnosis and treatment, and to understand the biological pathways involved in the disease to develop targeted treatments.

Statistics:

  • 96% accuracy rate for the new blood test for ME/CFS.
  • 92% sensitivity in identifying ME/CFS.
  • 98% specificity in identifying ME/CFS.
  • 400,000 people suffer from ME/CFS in the UK.
  • 47 patients with severe ME/CFS and 61 healthy controls were included in the study.

Sources:

  • "Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch 3-dimensional genomic regulatory immuno-genetic profiling" published in the Journal of Translational Medicine.
  • "Uea Launches New Blood Test for Chronic Fatigue Syndrome (Me/Cfs)" reported by VerticalNews Health on 2025 OCT 26.

Read more